312 related articles for article (PubMed ID: 30012432)
1. Obesity and Weight Gain Are Associated With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Kim Y; Chang Y; Cho YK; Ahn J; Shin H; Ryu S
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):543-550.e2. PubMed ID: 30012432
[TBL] [Abstract][Full Text] [Related]
2. Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non-alcoholic fatty liver disease.
Kim Y; Chang Y; Cho YK; Ahn J; Shin H; Ryu S
Liver Int; 2019 Oct; 39(10):1884-1894. PubMed ID: 31226232
[TBL] [Abstract][Full Text] [Related]
3. Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study.
Koo DJ; Lee MY; Jung I; Moon SJ; Kwon H; Park SE; Rhee EJ; Lee WY
PLoS One; 2021; 16(8):e0255535. PubMed ID: 34432804
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage.
Siddiqui MS; Yamada G; Vuppalanchi R; Van Natta M; Loomba R; Guy C; Brandman D; Tonascia J; Chalasani N; Neuschwander-Tetri B; Sanyal AJ;
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1877-1885.e5. PubMed ID: 30616027
[TBL] [Abstract][Full Text] [Related]
5. Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis.
Jung CH; Rhee EJ; Kwon H; Chang Y; Ryu S; Lee WY
Endocrinol Metab (Seoul); 2020 Mar; 35(1):165-176. PubMed ID: 32207277
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Six Noninvasive Methods for the Detection of Fibrosis in Chinese Patients with Obesity and Nonalcoholic Fatty Liver Disease.
Chen G; Yang JC; Zhang GX; Cheng Z; Du X
Obes Surg; 2022 Nov; 32(11):3619-3626. PubMed ID: 36070119
[TBL] [Abstract][Full Text] [Related]
7. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
8. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.
Kim D; Kim WR; Kim HJ; Therneau TM
Hepatology; 2013 Apr; 57(4):1357-65. PubMed ID: 23175136
[TBL] [Abstract][Full Text] [Related]
9. The severity of NAFLD is associated with the risk of urolithiasis.
Qin S; Wang J; Zhou C; Zhang Y; Xu Y; Wang X; Wang S
Br J Biomed Sci; 2019 Apr; 76(2):53-58. PubMed ID: 30430908
[TBL] [Abstract][Full Text] [Related]
10. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.
Joo SK; Kim W; Kim D; Kim JH; Oh S; Lee KL; Chang MS; Jung YJ; So YH; Lee MS; Bae JM; Kim BG
Liver Int; 2018 Feb; 38(2):331-341. PubMed ID: 28796410
[TBL] [Abstract][Full Text] [Related]
11. Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease.
Simon TG; Henson J; Osganian S; Masia R; Chan AT; Chung RT; Corey KE
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2776-2784.e4. PubMed ID: 31077838
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Performance of Noninvasive Tests for Advanced Hepatic Fibrosis in Young Age Population.
Kim M; Yoon EL; Lee J; Cho S; Lee CM; Kang BK; Park H; Jun DW; Nah EH
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1831-1840.e12. PubMed ID: 37115504
[TBL] [Abstract][Full Text] [Related]
13. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
[TBL] [Abstract][Full Text] [Related]
14. AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease.
Peleg N; Issachar A; Sneh-Arbib O; Shlomai A
Dig Liver Dis; 2017 Oct; 49(10):1133-1138. PubMed ID: 28572039
[TBL] [Abstract][Full Text] [Related]
15. The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients.
Singh A; Le P; Peerzada MM; Lopez R; Alkhouri N
J Clin Gastroenterol; 2018 Mar; 52(3):268-272. PubMed ID: 28787358
[TBL] [Abstract][Full Text] [Related]
16. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.
Mansoor S; Yerian L; Kohli R; Xanthakos S; Angulo P; Ling S; Lopez R; Christine CK; Feldstein AE; Alkhouri N
Dig Dis Sci; 2015 May; 60(5):1440-7. PubMed ID: 25540086
[TBL] [Abstract][Full Text] [Related]
17. Liver fibrosis markers and all cause mortality in people with type 2 diabetes: A population based study (The Ayrshire Diabetes Outcomes Cohort (ADOC) Study).
Collier A; Curran C; Cameron L; Wild SH; Byrne CD
Diabetes Obes Metab; 2023 Sep; 25(9):2659-2668. PubMed ID: 37311724
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
[TBL] [Abstract][Full Text] [Related]
19. Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study.
Pitisuttithum P; Chan WK; Piyachaturawat P; Imajo K; Nakajima A; Seki Y; Kasama K; Kakizaki S; Fan JG; Song MJ; Yoon SK; Dan YY; Lesmana L; Ho KY; Goh KL; Wong VWS; Treeprasertsuk S
BMC Gastroenterol; 2020 Apr; 20(1):88. PubMed ID: 32252638
[TBL] [Abstract][Full Text] [Related]
20. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease.
Angulo P; Bugianesi E; Bjornsson ES; Charatcharoenwitthaya P; Mills PR; Barrera F; Haflidadottir S; Day CP; George J
Gastroenterology; 2013 Oct; 145(4):782-9.e4. PubMed ID: 23860502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
